Interventional Oncology for Small Liver, Kidney, and Lung Tumors: Current Evidence and Emerging Treatment Strategies
Image-guided ablation can treat small tumors while limiting tissue loss, but its clinical value also depends on the burden imposed on patients. This critical narrative review examines imaging, treatment selection, comparative outcomes, and follow-up for liver, renal, and lung tumors. A PubMed search, citation tracking, and targeted guideline and primary-study checks informed a nonexhaustive synthesis. Randomized evidence supports ablation in defined hepatocellular carcinoma and colorectal liver metastasis populations, subject to trial eligibility and stopping rules. Renal and pulmonary comparisons remain predominantly observational; partial nephrectomy, contemporary lung-sparing surgery, surveillance, and stereotactic radiotherapy provide distinct alternatives. Tumor biology, achievable margins, adjacent structures, functional reserve, competing mortality, and patient preferences are more informative than diameter alone. Protective maneuvers can improve access in selected anatomically difficult cases. Hepatic irreversible electroporation and histotripsy broaden technical possibilities, but their oncological evidence and safety constraints require careful interpretation. Technical success, follow-up efficacy, retreatment, survival, and functional outcomes must be reported separately. Prospective comparisons should measure durable cancer control alongside anesthesia, hospital use, recovery, quality of life, and cumulative treatment burden. Treatment selection should integrate these outcomes through shared decision-making.
Authors
- Carolina Lanza (ORCID: https://orcid.org/0000-0002-8286-1562)
- Velio Ascenti (ORCID: https://orcid.org/0000-0001-8041-4075)
- Pierluca Torcia (ORCID: https://orcid.org/0000-0001-7807-4702)
- Pierpaolo Biondetti (ORCID: https://orcid.org/0000-0002-2737-2053)
- Salvatore Alessio Angileri (ORCID: https://orcid.org/0000-0001-7480-419X)
- Anna Maria Ierardi (ORCID: https://orcid.org/0000-0002-4160-8018)
- Serena Carriero (ORCID: https://orcid.org/0000-0003-2583-4215)
- Irene Carmen Pizza
- Martina Pedullà
- Jacopo Pozzi (ORCID: https://orcid.org/0009-0000-6564-6724)
- Jacopo D’Argenzio (ORCID: https://orcid.org/0009-0005-4218-3292)
- Desire’E Eboli
- Paolo Mastromarino
- Gianpaolo Carrafiello
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/jcm15229094
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00